Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Gynecologic 1CNS 1

Conditions

Neoplasms 8Fatigue 6Breast Neoplasms 5Anxiety Disorders 3Psychological Well-Being 2Pain 2Lung Neoplasms 2Gastrointestinal Neoplasms 2Esophageal Neoplasms 2Depression 2Caregiver Burden 2Uterine Neoplasms 1Tuberous Sclerosis 1Substance-Related Disorders 1Smoking Cessation 1Sleep Wake Disorders 1Sleep Initiation and Maintenance Disorders 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Pain, Postoperative 1Ovarian Neoplasms 1Neoplasm Regression, Spontaneous 1Multiple Myeloma 1Malignant Hepatobiliary Neoplasm 1Lymphoma 1Leukemia 1Hematopoietic Cell Transplantation Recipient 1Head and Neck Neoplasms 1Glioblastoma 1Colorectal Neoplasms 1

Interventions

Cisplatin 109Radiotherapy 100Fluorouracil 90Paclitaxel 75Oxaliplatin 63Docetaxel 56Carboplatin 55Irinotecan 41Esophagectomy 41Leucovorin 40Capecitabine 39Surgical Procedures, Operative 36Radiation 36Drug Therapy 31Neoadjuvant Therapy 25Chemoradiotherapy 18Cetuximab 18S 1 (combination) 17pembrolizumab 16camrelizumab 16Nivolumab 15Magnetic Resonance Spectroscopy 15Bevacizumab 15Blood Specimen Collection 14Surveys and Questionnaires 12Radiotherapy, Intensity-Modulated 12Immunotherapy 11Epirubicin 11Biopsy 11Trastuzumab 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Esophageal Neoplasms × Acceptance and Commitment Therapy × Clear all
NCT01929720 2017-04-05

FOCUS

Ohio State University Comprehensive Cancer Center

Phase NA Completed
33 enrolled
CNSGastrointestinalGynecologicLymphoidOther hematologic neoplasmPlasma cellThoracic

Anxiety Disorders, Depression, Esophageal Neoplasms, Fatigue, Glioblastoma, Sleep Initiation and Maintenance Disorders, Leukemia, Lung Neoplasms, Lymphoma, Multiple Myeloma, Neoplasms, Ovarian Neoplasms, Pain, Pancreatic Neoplasms, Sleep Wake Disorders, Uterine Neoplasms

NCT02491372 2016-04-05

A Pilot Study of the Effectiveness of Acceptance and Commitment Therapy With a Post-Upper GI Cancer Population

Queen's University, Belfast

Phase NA Withdrawn
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡